<DOC>
	<DOCNO>NCT01232855</DOCNO>
	<brief_summary>RATIONALE : Studying sample fo tissue patient cancer laboratory may help doctor identify learn biomarkers related cancer . PURPOSE : This research study study biomarkers tissue sample patient acute promyelocytic leukemia .</brief_summary>
	<brief_title>Biomarkers Tissue Samples From Patients With Acute Promyelocytic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Demonstrate S100A10 express APL cell level S100A10 correspond amount fibrinolytic activity . - Evaluate impact ATRA S100A10 level fibrinolytic activity vitro . - Evaluate impact S100A10 knockdown fibrinolytic activity . - Correlate vitro finding cell culture primary patient sample pre- post-ATRA therapy . OUTLINE : This multicenter study . Previously collect sample analyze via flow cytometry western blot analysis . Cell surface level S100A10 annexin A2 correlate promyelocyte population total protein level examine determine total annexin A2 S100A10 acute promyelocytic leukemia cell .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Promyelocytic , Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute promyelocytic leukemia Available cryopreserved cell diagnosis cryopreserved cell remission ( germline ) PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>adult acute myeloid leukemia ( 15 ; 17 ) ( q22 ; q12 )</keyword>
	<keyword>adult acute promyelocytic leukemia ( M3 )</keyword>
	<keyword>childhood acute promyelocytic leukemia ( M3 )</keyword>
	<keyword>adult acute myeloid leukemia remission</keyword>
	<keyword>untreated adult acute myeloid leukemia</keyword>
	<keyword>childhood acute myeloid leukemia remission</keyword>
	<keyword>untreated childhood acute myeloid leukemia myeloid malignancy</keyword>
</DOC>